Arvinas, Inc. (ARVN)
11.84
-1.26
(-9.59%)
USD |
NASDAQ |
Feb 12, 16:00
11.70
-0.14
(-1.14%)
After-Hours: 06:09
Arvinas Free Cash Flow : -329.50M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc. | 10.38B |
| Genprex, Inc. | -15.08M |
| Olema Pharmaceuticals, Inc. | -134.67M |
| ACADIA Pharmaceuticals, Inc. | 98.97M |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -59.10M |
| Cash from Investing (Quarterly) | 63.50M |
| Cash from Financing (Quarterly) | -17.80M |
| Free Cash Flow Per Share (Quarterly) | -0.8087 |
| Free Cash Flow to Equity (Quarterly) | -58.60M |
| Free Cash Flow to Firm (Quarterly) | -59.20M |
| Free Cash Flow Yield | -38.27% |